MARKET

BIOL

BIOL

Biolase Inc
OTCMQB
0.082
-0.013
-13.58%
Closed 15:05 07/12 EDT
OPEN
0.080
PREV CLOSE
0.095
HIGH
0.089
LOW
0.080
VOLUME
22.59K
TURNOVER
1.85K
52 WEEK HIGH
10.31
52 WEEK LOW
0.040
MARKET CAP
2.74M
P/E (TTM)
-0.0040
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BIOL last week (0701-0705)?
Weekly Report · 4d ago
Weekly Report: what happened at BIOL last week (0624-0628)?
Weekly Report · 07/01 10:09
Weekly Report: what happened at BIOL last week (0617-0621)?
Weekly Report · 06/24 10:12
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Nexalin Technology (NASDAQ:NXL) stock increased by 48.1% to $1.54 during Wednesday's after-market session. Tempest Therapeutics ( NASDAQ:TPST) stock moved upwards by 40.0% during the session. ASLAN Pharma (NASdaq:ASLN) shares increased by 18.51%.
Benzinga · 06/19 20:30
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Sonoma Pharmaceuticals (NASDAQ:SNOA) shares rose 60.2% to $0.27 during Wednesday's pre-market session. The company's market cap stands at $1.0 billion. Mustang Bio, Geovax Labs, Onconetix and Silk Road Medical also moved upwards. Losers include DermTech, Biolase and Zentalis Pharma.
Benzinga · 06/19 12:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Nexalin Technology (NASDAQ:NXL) shares rose 55.8% to $1.62 during Tuesday's after-market session. Dynatronics stock rose 14.74% and Oncology Institute shares moved upwards by 10.8%. SAB Biotherapeutics stock rose 8.94% during the session.
Benzinga · 06/18 20:31
BIOLASE announces delisting from Nasdaq
BIOLASE announces delisting from Nasdaq Jun. 18, 2024. Suspension of trading in the company's common stock on the Nasdaq exchange will be effective at the open of trading on June 20, 2024, BIOLASE says. The delisting is a result of failure to satisfy Nasdaq Listing Rule.
Seeking Alpha · 06/18 20:10
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Sonoma Pharmaceuticals (NASDAQ:SNOA) stock increased by 63.8% to $0.28 during Tuesday's pre-market session. The company's Q4 earnings report came out yesterday. Qualigen Therapeutics stock rose 31.57% and Mustang Bio shares rose 30.66%.
Benzinga · 06/18 12:07
More
About BIOL
BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse.

Webull offers BIOLASE Inc stock information, including OTCMQB: BIOL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIOL stock methods without spending real money on the virtual paper trading platform.